Cooperative Agreement 2450913
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$1.2M
Federal Agency
National Science Foundation
Awardee
Sostos Inc. (TW4LF32FLS31)
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Everettville, WV 26505, USA
Similar Awards
This $305,000 Project Grant was awarded on June 1, 2025 by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program. The purpose of the grant is to develop a cloud-based software platform that can identify multi-omics biomarkers critical for guiding non-small cell lung cancer treatment decisions. The software solution will feature a data portal providing access to validated biomarkers for predicting tumor recurrence/metastasis and drug...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $365,887 to The Research Foundation For The State University Of New York (RF SUNY) to develop an innovative artificial intelligence (AI) technology to select optimal treatment options for individual cancer patients. The goal is to prolong patient life by tailoring treatments to each patient, which can also reduce healthcare costs by avoiding...
This Cooperative Agreement award from the National Science Foundation (NSF), under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $1,250,000 in funding to Rattan Life Science Inc., a self-certified small disadvantaged business, for the development and validation of a novel platform technology to enable the scalable generation of high-quality, tumor-targeted induced naïve T cells for off-the-shelf cancer immunotherapies. The project aims to increase the...
This $1,008,000 Cooperative Agreement award was provided by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a high-throughput platform for screening millions of T-cell receptors (TCRs) against a large set of clinically relevant cancer antigens, in order to identify and validate promising TCRs for cancer-specific cell killing. The goal is to discover and validate multiple anti-cancer TCRs that could...
This $1,168,047 Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop a deeper understanding of the complex problems and needs that drive technology innovation. The project involves: Collecting comprehensive datasets on technical problems, solutions, and organizations across three selected domains; 2) Applying AI/machine learning techniques to analyze this data and identify predictive...
The National Science Foundation (NSF) awarded a $1,213,619 Cooperative Agreement under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Encapsulate Inc., a small disadvantaged business in Farmington, CT. This Phase II Small Business Innovation Research (SBIR) project aims to develop a precision oncology platform that integrates microfluidics, biochips, bioreactors, and 3D tumor models to predict patient-specific cancer drug responses. The proposed technology utilizes...
This Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $999,878 to Akttyva Therapeutics, Inc., a small business located in Watertown, MA, to develop an AI-assisted drug discovery platform to identify existing drugs and new chemical entities capable of repairing vascular permeability barriers. The project aims to address unmet clinical needs for conditions like acute respiratory distress...
This Project Grant award of $304,929.00 from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of new artificial intelligence (AI) models that utilize causal understanding and reasoning. The project aims to create a methodology for developing AI models that can provide reliable, traceable, and human-comprehensible analytics and decision-making for healthcare applications. The goal is to overcome the limitations of...
This $997,693 Cooperative Agreement awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an interactive health assessment and monitoring platform to improve patient-provider communication and reduce healthcare costs. The project by Literaseed, Inc. integrates electronic health record (EHR) data with natural language processing (NLP) techniques to extract valuable information from medical records, enabling...
This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,932,818 to Insilicom LLC, a woman-owned, minority-owned small business, to develop an enhanced knowledge graph focused on technology-related entities and their relationships. The project aims to leverage natural language processing and predictive modeling to extract information from diverse text sources, including PubMed abstracts, patents,...